Bowen Hanes & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bowen Hanes & Co's LLY Position: Q2 2026 in Review
Bowen Hanes & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 114,646 shares worth $105M. The position accounts for 2.57% of the portfolio, ranked #7.
Bowen Hanes & Co first reported a position in LLY in Q4 2018 and has held it in 20 quarters since. The position peaked at $124M in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bowen Hanes & Co held 114,646 shares of Eli Lilly worth $105M as of Q2 2026.
- Bowen Hanes & Co left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 2.57% of Bowen Hanes & Co's portfolio in Q2 2026, its #7 holding.
- Bowen Hanes & Co first reported a position in Eli Lilly in Q4 2018 and has held it in 20 quarters since.
- Bowen Hanes & Co's Eli Lilly position peaked at $124M in Q4 2025.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bowen Hanes & Co's 13F filing for Q2 2026, filed 13 Aug 2026.